Search results
Results from the WOW.Com Content Network
The COVID-19 pandemic in Nova Scotia is an ongoing viral pandemic of coronavirus disease 2019 , a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 . On March 15, 2020, three presumptive cases in Nova Scotia were announced.
The COVID-19 pandemic in Canada is part of the ongoing worldwide pandemic of coronavirus disease 2019 . It is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Most cases over the course of the pandemic have been in Ontario, Quebec, British Columbia and Alberta. Confirmed cases have been reported in all of Canada's ...
1.2 Timeline of cases and deaths by province and territory. 1.3 Overview of infection waves. 1.4 Breakdown by year. 1.5 Deaths by year. ... COVID-19 cases in Canada ...
Pages in category "COVID-19 pandemic in Canada by province or territory" The following 19 pages are in this category, out of 19 total. This list may not reflect recent changes .
Since 15 March 2020, Strang has provided daily updates on the COVID-19 pandemic in Nova Scotia. He became Nova Scotia's public health lead communicator on matters related to the COVID-19 pandemic in Nova Scotia. In daily press conferences, he provides updates on the COVID-19 pandemic and the public health effort to respond to it. [9]
The COVID-19 pandemic in New Brunswick is an ongoing viral pandemic of coronavirus disease 2019 , a novel infectious disease caused by severe acute respiratory syndrome coronavirus 2 . The province of New Brunswick has the eight-most cases (out of ten provinces and three territories) of COVID-19 in Canada , having confirmed their first case on ...
At the same time, the province reached a new "marker in the pandemic"—the COVID-19 vaccines supply exceeded "demand on a daily basis." [2] [44] By early August at the beginning of the fourth wave, case numbers and test positivity rates were declining in Manitoba in spite of the increase in the proportion of cases of Delta.
On May 6, 2020, the NRC reached an agreement with Chinese pharmaceutical company CanSino Biologics to conduct clinical trials for its COVID-19 vaccine candidate Ad5-nCoV at Dalhousie University in Nova Scotia. [24] The NRC cited its "strong collaborative history" with CanSino, and past work on adenovirus vaccines, as part of its decision. [19]